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m103668 ActualSamaDayDiachargeAfterSuccessfulPTCA:OutcomeoftheOUTCLAS-PilotStudy
T. Slagboom, F. Kiemeney, G. Laarman, R. van der Wieken. Arrrsterdarrr
Department of Interventionai Cardiology (ADIC)-OLVG,Amsterdam, The
Netherlands
The aim of the OUTCLAS WPatiOnt Coronary Low-Profile An9ioPkiatY
study), a large proapactive single center atudy is to test the safety and
feasibility of actual same day discharge after PTCA in a low-risk patient
group, based on a setof previously tested clinical and angiographic param-
aterdpredietore of acute occlusion in the first 24 hours. Patients selected
for elective balloon angioplasty or stent implantation for single or multivessel
disease, for stable and unatable angina, were included.
PTCA was performed with 6 French Catheter equipment and under a
low dose of Heparin (5000 W for PTCA, 10.OW for stent), using the radial
attery approach. Immediate post-procedural sheath removal, together with
the former measures, are imperative to facilitate eerlyambulation, necessary
for same day discharge.
in 4 months 159 patients were included. 106 patients (67%) were selacted
for same day discharge baaed on our predefine parameters. 42 (40%)
patients in the outpatient group received one or more intracoronary stents
either elective orforsuboptirnal PTCA result. 24 hourtelephonefollow upwas
uneventful in all patients with regard to cardiac and vascular complications.
53 patients (33Yo) were selected for 24-hour hospital atay, most of them on
continuous haperin infusion. In 9 patients (17Yo)a stent wee implanted. Three
r)atients had abrupt vesael closure, <1 hour after successful PTCA. 1 patient
sustained a TIA.
Conclusion: Selected patients can be safely discharged on the same day
that transredial PTCA is performed, with minimal risk for cardiac or vascular
eomcdieationa.if a aet of determinants for acute vessel closura is applied and
if adbquate ~theter equipment ia used.
11036-89I CompariaOnofCiinka,and~conomic~utcomea
of Radialva. FemoralAccesaSiteainCoronary
Stenting
J.T. Mann, G. Cubeddu, J. Bowen, M.E. Arrowoed, J.E. Schneider. Wake
Heafl Centec Raleigh, NC, USA
Clinical and economic outcomes were retrospectively evaluated in 719 pa-
tients (pte) who underwent coronary stenting using the radial (R) and femoral
(F)acoesssitesbetween 12/94-W6. Baseline demographicswere similarfor
tnth groups. Primary auccess rate, number of pts managed with Ticlicf/ASA
alone, vaacular Complications (VC), poet procedure (PP) and total hospital
(TH) length of atay (LOS), oath lab charge (CLC) and TH charge (THC) were
compared. Results are as follows:
Femoral Radial P Value
Patients, n 413 Sos
Primary success, “A 9s 95 NS
TIcIWASA,“A 68 71 NS
Vc, Y. 5 0.3 <0.01
PPLOS,days+ SEM 3.2+ 0.13 2.2* 0.12 <0.01
THLOS, days+ SEM 5.5 l 0.20 3.s+ 0.20 <0.01
CLC,$ + SEM 7,069* 115 6,563+ 116 <0.01
THC,$ + SEM 24,218+ 5S0 19,675+ 520 <0.01
Cone/usiorr:1)Coronaw stenting can be performed from the radial ap-
proach aa successfully as the femoral approach with fewer vascular impli-
cations. 2) There waa a 19% reduction in hospital charge in the transradial
group due to significantly shorter hospital length of stay and lower cath lab
charges.
11036-90]*venFmnCh(7F)Transradia, APProachA,,~~a
WidespreadUseof CoronaryStentingWithLow
ComplicationRateInSelactedPatienta
C. Karam, C. Lohbeyre, J. Fajadet, J.-C. Leborde, C. Jordan,
B. Caaeagneau, J.-P. Laurent, J. Marco. Cliniqua PasteuL Toulouse,France
Transradial (TR) 6 F is a safe approach for PTCA, associated with an early
discharge and a low complication rate. Some stents (S) cannot be used
through 6 F guiding Catheters. In patients (Pts) with strong radial pulse and
favorable Allen test, 7 F TR approach can be performed and allows wider
S choice. Between May and August 1996, 161 Pts underwent PTCA via 7
F TR approach, with successful vascular access in 174 (97.1%), 145 men
and 29 women, mean age 64.5 + 10.5 yeare, with unstable angina (40%),
arable angina (4WO) or reeent Ml (12%). PTCA was successful in 97.7%
of the Pts, of whom 22% had 2 vessels dilated during the proeadure. The
dilated vessel waa either LAD (36Yo), LCX(25Yo),RCA (33%) or graft (6Yo).
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Mean lesion length was 13.9 + 8 mm. ACCIAHA lesion type waa A in 12%,
B in 66% and C in 22%. Stenting rate wee 74% with a mean of 1.4 SPt.
We used Gianturco-Roubin (40%), RX Multilink (22%), NIR S (II%), Magic
Wallstent (7%), Palmaz-Schatz (7%), Insb?nt(4%) and other S in 9%. Final S
diameter was 3.39 + 0.36 mm. Vascular access complications consisted of
one subclavian dissection and one forearm hematoma. We compared major
events during hospital stay with those of 179 Pts undergoing PTCA at the
same period via 6 F TR approach, and we did not obsewe any significant
difference between both groups.
Success sccess Death CABG Ml SAT “/.Vaac
% % % % % comnllc
7F 97.1 1,1 0.5 0.5 0 1,1
6F 9s.s 0.5 0 0.5 0,5 0.5
0 NS NS NS NS NS NS
Seven F TR approach is feasible with same in-hospital resulta as 6 F but
allows wider S choice in type and diameter.
11036-91/ ThenewlnFlowStent:CliniCa,andAngiOgraphiC
Reaulta
E. Alt, S. Elezi, E.-M. Zitzmann, J. Hausleiter, A. Rybnikar, A. Schbmig. L
Med. Klinik, K/inikum rechts der Lsarand Deutsches Herzzentrum,
German& T%hnische Univereit~t Miirrchen, Germany
Stent designs favoring good vascular support are necessary to reduce recoil
but confer decreased flexibility, limiting the use in complex Coronarylesions.
The balloon expandable stainless steel InFlow stent is a novel laser-cut
tube stent consisting of linked, circumferential sinusoidal struts with oval
strut cross sections. To assess the utility of this advanced stent design, 336
stents of various length (242 = 7 mm, 54 = 9 mm, 35 = 11 mm, 7 = 15
mm) were implanted in 164 Ieaions (8 LM, 74 LAD, 70 RCA, 32 LCX) in
108 patients. 14% type A, 13% Bl, 38% B2, 35% C. The mean length of
stented segments per patient was 25.2 mm. 22 patients were stentsd in acute
myocardial infarction. Stents were manually folded onto standard angioplaaty
balloons. Patients were treated with 100 mg aspirin and 250mg ticlopidine
bid. Angiographic reaults were analyzed by QCA.
Results: Stent deployment was successful in 1641165lesions (99.5%).
Mesn maslmumballoonpressurewss: 11.S* 1.7atm.
Minimallumendiameter (mm) 0.76+c 0.4S
pereentstenosis (%) 74.5* 14.7
balloon-to-vesselratio 1.01 i 0.09
refersnce diameter poststsnt (mm) 3,05+ 0.5
minimalIumandiameter poststent (mm) 2.s4+ 0.49
residualstenosispoststent (o/o) 6.8 *4.1
acute recoil(%) 4,7* 3.4
At 30 daya follow-up there ware two acute stent thromboees, one restenoeia
needing re-PTCAandonemajor groin hematoma requiring ultrasound-guided
manualcompression. There were nodeatha, myocardial infarctions orCABG.
Conclusion: The new InFlow stent exhibits low recoil while retaining
high procedural suceeas aven with eompticatsd Ieaions. With combined
antiplatelet therapy, it provides favorable clinical and angiogrsphic reaulta
without the need for high pressure balloons.
m103692 TheNewGianturco-RoubinCoronaryStentisanImprovedTherapyforAbruptandThreatened
ClosureSyndroma
C.D. O’Shaughnessy, J.J. Popma, L.S. Dean, E.T.A. Fry, J.P. Carrozza,
W.D. Knopf, D.J. Kereiakea, B.S. George, M.A. Thompson, J.A. Brinker,
A.E. Raizner, M.B. Leon. Nor?hOhio Heart Centec E/yrfa, OH, USA
To address the limitations of previous Coronary stent designa for the treat-
ment of abrupthhreatened closure (AC), the new Gianturco-Roubin (GRII’”)
stent has a more flexible geometry, improved scaffolding, radio-opaque end-
markers, and variable lengths (20 mm and 40 mm). Thus far, the firat 275
consecutive patients have been analyzed from 23 centers in the GR117”AC
registry. Earlier treatment of dissections was emphasized and the majority of
pts (91%) had thrsatened(TIMl > O)closure syndrome. Lesions treated were
extremely complex with B2/C class 83%, proximal tortuosity 73%, diffuse dia-
ease 58% (lesion length 18.7 + 12.0 mm), bifurcation 27%, and > type B
diesections54%. Nevertheless, successful (GRllm), placement waaachievsd
in 273/275 (99.3%) pte (average 1.7 StOntSper pt; 34% 40 mm stente) with
complete resolution of diaseetions in 69%, resumption of TIMI 3 flow in 96%,
and final % diameter stenosis 2.47.. Despite ASA plus ticlopidine treatment
in all pts (some with additional anticoagulation), aubacute stent thrombosis
(SAT)occurred in 12 (4.4%) pts; 6 events in the first24 hours. Major adverae
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coronary events @ 30 days included death 1.5%, Q-wave Ml 1.1%, CABG
3.6%, and repeat PTCA 3.6% (ANY event in 6.7% pts).
/n Corrc/usion: the new GRII’” coronary stent provides improved deliv-
erability to complex lesion sites with excellent resolution of AC syndromes.
However, additional therapies may be required (e.g. stent coatings, ReoPro)
in AC pts to reduce SAT and diminish 30-day major adverse clinical events.
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-j EchocardiographycanPredicttheDevelopment
of SevereMitralReauraitetionAfterPercutaneous
MitralValvuloplae~-W~hthe Inoue(Single
Balloon)Technique
L.R. Padial, V.M. Abeacel, P.R.Moreno, A.E. Weyman, R.A. Lavine,
LF. Palacioa. Massachusetts General Hospital, Haward Medicel School,
Boston, MA, USA
We have previously described an echocardiographic score (MR-Echo Smre)
based on mitral valve morphology (unevenly thickened leaflets, diffuse in-
volvement of the commissures and subvalvular apparatus) which can predict
the development of aevere mitral regurgitation (MR) after percutaneous mi-
tral valvuloplasty (PMV) using the double balloon technique. Whether the
same score can be uaed to predict severe MR in patients undergoing PMV
with the Inoue technique is unknown. Therefore, we prospectively studied
60 consecutive patients (11 men; 57 + 14 yrs) who underwent PMV by the
Inoue technique. Eleven patients developed severe MR (angio ? 3+) after
the procedure. No significant differences were obsenfed between them and
those who did not develop savere MR in age (60 + 10 vs. 57 + 14 yrs; p =
0.40), Wilkins’ score (6.7 + 1.5vs. 7.6 +2.0; p =0.06) or dilating balloon size
(26.7 + 1.1 vs. 27.1 + 1.5 cm; p= 0.07), whereas a significant difference was
noted in MR-Echo Score (10.5 + 1.4 vs. 6.2 + 1.1; p = 0.0001). Nine (62%)
patients with severe MR and 6 (9%) without MR had an MR-Echo Score
z 10 (p < 0.00001). Thus, the MR-Echo Score has a sensitivity of 6.20/.,a
specificity of 91%, a positive predictive valUe of 60Y0,a negative predictive
valUOOf 97% and an accuracy Of 90?’. fOr predicting the development Of
severe MR after PMV with the Inoue technique, similar to those with double
balloons. In conclusion, MR-Echo Score can also predict the development of
severe MR in patients undergoing PMV with the Inoue technique.
m103778 Transluminalendovasculargraftplacementforthetreatmentof thoracicaorticaneuryems
K. Inoue, T. Iwase, M. Sate, Y.Yoshida, S. Tamaki, A. Yamazato,
H. Hosokawal, T. Suzuki 1. TakedaHoapital, Kyoto, Japan, 1SVations/
ToyohashiEast Hospital, Aichi, Japan
Redescribe ourinitialclinicel experience in repainngthoracic aorticaneurysms
using a new device. The procedure was performed in 13 patients with tho-
racic aortic aneurysm. The endovascular grafting system was designed and
developed by Inoue et al.The new graft was constructed from a Dacron
cylinder and the surface of the graft was supportad by multiple rings of
extra-flexible wire. After the folded graft was delivered to the predetermined
target point through the eheath, the graft was deployed, and then pressed
against the aortic wall by balloon inflation. Straight graft insertion was at-
tempted in 11 patients and branched graft insertion in 2 patients. There were
trua aneurysm in 2 patients, aortic dissection in 9, true aneurysm and aortic
dissection in 1, pseudoaneurysm in 1. The implantation site was the distal
arch in 6 patients, and the descending thoracic aorta in 7. The grafts were
successfully placed in 12 patients and technical failure occurred in 1. The
procedure was terminated because the branched graft did not pass through
the 22 French sheath. Thrombeais of the aneurysm surrounding the graft
was complete in 7 patients within one week. The remaining 5 patients had
either proximal communication or diatal communication with the aneurysm.
Thedegreeof leakage was mild in 3 patients, moderate in 2. We encountered
microembolization in 1 patient. For 1 patients with moderate leakage, second
endovascular placement of the branched graft waa successfully performed.
Three patients with mild leakage have continued to be obeewed closely.
There have been no deaths or instances of paraplegia. There have been
no graft migration, extrevasation, resultant aneurysm, evidence of aneurysm
enlargement, graft distraction or significant graft stenosis during a mean
follow-up period of 9 months. Initial clinical results demonstrated the efficacy
and safely of endovascular graft placamant using the new graft.
11037-79I BalioonAngioplastYofNativeCoarctationin
AdolescentsendAdults,2-10 YearFollowUp
Results
ME. Fawzy,V, Sivanandam, A. Rifai, B. Dunn, W. von Sinner, A.A. Patel,
J. Lingamanaicker, K.A. Niazi, King Faisa/ Specialist Hospita/& Research
Centre, Riyadh, Saudi Arabia
The long term result of balloon angioplasty (BA) in adult aortic coarctation
(AC) has not been well characterized. 41 consecutive adult patients (pta) with
nativeAC underwent BAbetween July 1966and July 1996.Theirages ranged
from 15-55 (mean 22 + 7) years (yrs). Dissection of the aorta developed in
one patient. Datawere collected on the remaining 40 pts. Clinical examination
and serial study by cardiac catheterization and magnetic resonance imaging
(MRI) were carried out in 36 pts, 2-10 yrs (mean 6 yrs) after dilatation.
Resu/ts:Peaksystolic gradient (PSG) before dilatation was36-100 (mean
64 + 24) mmHg and decreased to 12 + 8 mmHg p <0.001 immediately
after dilatation. Restenosis (defined as gradient >30 mmHg across AC site)
occurred in 2 pts and 1 pt had incomplete dilatation. The 3 pts underwent
rediiatation and remain improved 5 years later. There was no significant
change in PSG across AC in the remaining 26 pts at follow up, it ranged from
0-15 (mean 7.5 + 6) mmHg, Three pts developed small aneurysms which
did not increase in size 5 years later, Blood pressure was controlled without
medication in 27 pts and required medication in the remaining pts.
Conclusion: (1) It is concluded that the long term result of balloon angio-
plasty of nativa coarctation in adolescents and adults is satisfactory. (2) The
blood pressure normalized in 75% of patients without medication,
[-l An EchOcardiOgraphicStudyof the MitralVakein
PatientsWhoFailto Increasethe MitralValve
AreaAfterPercutaneousMitralValvuloplasty:
Roleof CommissuresandSubvalvularDisease
L,R. Padiai, V.M. Abascal, P.R.Moreno, A.E. Weyman, R.A, Levine,
LF. Palacios, Massachusetts General Hospital, Harvard Medical School,
Boston, MA, USA
Little is known about why some patients fail to increase mitral valve area
(MVA) after percutaneous mitral valvuloplasty (PMV). To study whether this
can be due to some morphologic features of the mitral valve, 12 patients (all
women; 59 + 11yrs) whose MVA did not increasa after PMV (change s 0.1
cm2) were compared with 100 consecutive patients (66 women; 56+ 14 yre;
31 double balloon PMV) whose MVA significantly increased. The mitral valve
was studied using a previously deecrfbed echocardiographic score aimed to.
predict the development of severe mitral regurgitation after PMV (MR-Echo
Score). This score takes into account unevenly thickened leaflets and diffuse
involvement of the commissures and subvalvular apparatus. No significant
differences were noted in age, MVA pre-PMV (1.0 + 0.1 vs. 0.9 + 0.2 cmz),
degree of MR pre-PMV, Wilkins’ score (7.9 + 2.5 vs. 7.7 + 1.9) or balloon
size (3.5 + 0.4 vs. 3.6 + 0.4 cm2/m2) between the two groups. Significant
differences were observed in the MR-Echo Score (10.3 & 2.3 vs. 6.1 + 1,1;
p = 0.0001) and its individual components for commissures (2.7 & 0.8 VS.
1.9 + 0.4; p = 0.0006) and subvalvular disease (3.0+ 0.9 vs. 2.1 + 0.6; p =
0,0002), without significant differences in the degree of leaflet diseaae.
Cone/uaion:Patients who fail to increase MVA after PMV have more se-
vere disease of the commissures and the subvalvular apparatus. This might
potentially limit commissural splitting and relief of subvalvular restriction.
m103781 Predictorsof MitralRestenosisFollowingMitralBalloonValvuloplastyin360Patients
M.E. Fawzy,V. Sivanandam, S. Wahi, L. Mimish, B. Dunn, K.A. Niezi,
O. Ismail, B.A. Khan, Z. Al Halees. King Faisa/ Specialist Hospita/ &
Research Centre, Riyadh, Saudi Arabia
Background: Mitral ballcrm valvuloplasty (MBV) is an effactive method in
the treatment of patients .(pts) with severa mitral stenosis (MS). Although
factors determining immediate result of MBV have been described, there
is little information regarding the predictors of restanosis following MBV.
Methods: From December 1969 to July 1996, 360 pts underwent successful
MBV for severe MS. 267 had completed clinical and Echo Doppler study
with a mean follow up of 42 + 15 (12 to 68) months. 49 pts developed
restenosis (16.4%), (defined as 50% loss of initial gain in Doppler mitral
valve area (MVA) or follow up MVA c 1.2 cm2). 3Y0 of pts of mitral Echo
score (MES) < 6 developed restenosis, and 6Y0 in those with MES = 6
and 56% with those >8 MES. Multivariate Cox Regression analysis of 10
different baseline characteristics: age, sex, atrial fibrillation, NYHA class,
MES, immediate Doppler MVA, mitral gradient, left atrial eize, cardiac index,
pulmonary arleriolar resistance. Resu/ts: The analysis identified that the
suboptimal result (immediate MVA <1.5 cm2), and high MES were the only
independent predictors of restenosis (P< 0.001).
